Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Quotient Sciences and Vasa Therapeutics Announce Dosing of First Subjects with VS-041, a Novel Heart Failure Treatment

    Sep 11, 2024, 09:32 AM by
    Full story
  • Verisense Health Introduces an iOS App for its Smart Watch

    Sep 11, 2024, 09:32 AM by
    The Verisense Smart Watch, Which Collects Digital Health Data During Clinical Trials, is Now Compatible with Both Apple and Android Smartphones.
    Full story
  • Envision Pharma Group launches EnvisionOne Insights: A unified data and analytics solution for medical affairs

    Sep 11, 2024, 09:32 AM by
    One of the world’s leading technology solutions companies Envision Pharma Group has launched “EnvisionOne Insights” an innovative medical technology solution for the power of big dat
    Full story
  • PharmaForceIQ Announces Majority Investment by Eir Partners to Support and Accelerate Growth

    Sep 11, 2024, 09:32 AM by
    PharmaForceIQ Announces Majority Investment by Eir Partners to Support and Accelerate Growth Miami, FL – 10th September 2024, PharmaForceIQ (PFIQ), the leading end to end Omnichannel Solution for Pharmaceutical Marketing, Medical and Clinical teams today announced a significant investment by Eir Partners (Eir) to accelerate adoption of the company’s unique technology platform and services for the Life Science industry.
    Full story
  • AI and Biotechnology: Navigating Opportunities and Risks in the Bioeconomy

    Sep 11, 2024, 01:00 AM by User Not Found
    Bio-IT World | Last month’s Bioprocessing Venture, Innovation, and Partnering Conference brought together thought leaders from across the bioeconomy to discuss the rapidly evolving landscape of artificial intelligence (AI) in biotechnology.
    Full story
  • Researchers Add ‘New Piece to the Puzzle’ That is Celiac Disease

    Sep 10, 2024, 01:00 AM by User Not Found
    Bio-IT World | Celiac disease is a surprisingly common but substantially underdiagnosed autoimmune disorder estimated to affect 1 in 100 people globally. Left untreated, it can have “serious clinical consequences” for patients, including malnutrition, bone weakening, and potentially even a higher risk of certain cancers.
    Full story
  • APL and CurifyLabs partnership to support critically ill patients with 3D printing medicine technology

    Sep 6, 2024, 09:05 AM by
    Full story
  • Integrated DNA Technologies Bolsters Comprehensive Genomic Profiling Solutions with Launch of New Archer™ HRD Technology for Cancer Research

    Sep 6, 2024, 09:05 AM by
    Full story
  • Life Sciences Organizations Gain New Real-World Data Offering To Bring Precision Therapies And Diagnostics To Patients

    Sep 6, 2024, 09:05 AM by
    Proscia customers can leverage over 10 million de-identified pathology images alongside corresponding clinical and genomic data
    Full story
  • Global CDMO brings technological advancements & significant capacity to Ocean County, NJ location

    Sep 6, 2024, 09:05 AM by
    Full story
  • Andrew MacGarvey & Conditor Capital Launch Coronado Research to maximise the use of data and technology in drug development; Dr Nicholas Edwards announced as Chair

    Sep 6, 2024, 09:05 AM by
    Andrew MacGarvey & Conditor Capital Launch Coronado Research to maximise the use of data and technology in drug development; Dr Nicholas Edwards announced as Chair
    Full story
  • Medical University of Graz Selects the HALO AP® Digital Pathology Platform to Deliver Comprehensive Diagnostics

    Sep 6, 2024, 09:05 AM by
    Indica Labs has announced the Diagnostics & Research Institute for Pathology at the Medical University of Graz has selected the HALO AP® digital pathology platform from Indica Labs to deliver primary diagnostics, alongside Aperio GT 450 scanners from Leica Biosystems.
    Full story
  • FDA Issues Letter of Support for α-Synuclein Seed Amplification Assay – The Core Technology Used in Amprion’s First Commercial Test

    Sep 6, 2024, 09:05 AM by
    Novel assay detects misfolded α-syn in cerebrospinal fluid; A critical drug development tool that can enhance clinical trials and advance life-changing treatments for PD and other neurodegenerative disorders
    Full story
  • SPT Labtech and Synthace partner to accelerate drug discovery through accessible DOE

    Sep 6, 2024, 09:05 AM by
    Full story
  • Biotech’s Secret to Surviving Economic Challenges? It’s All in the Data & AI

    Sep 6, 2024, 01:00 AM by User Not Found
    Bio-IT World | Data has always been crucial in the life sciences industry, but in today's fiercely competitive landscape, its significance has skyrocketed. Amidst dwindling funding and mounting market pressures, biopharmaceutical companies need to better harness the power of information to design and accelerate clinical trials and timelines.
    Full story
  • InSysBio to launch Immune Response Template version 3.6.3 for QSP modeling

    Sep 5, 2024, 07:29 AM by
    InSysBio launches Immune Response Template (IRT) version 3.6.3. IRT represents a QSP platform of immune system, simultaneously, being a tool for development of models related to immune system. Veronika Musatova, Head of IRT development team, comments on the new version, “As a result of the update, B cells model reflects the current views on the processes and sequence of this cell type development maintaining a balance between the model detail and complexity.”
    Full story
  • VedaBio Appoints Dr. G. Brett Robb as Senior Scientific Director and Head of CRISPR Science

    Sep 5, 2024, 07:29 AM by
    VedaBio Appoints Accomplished Leader, Dr. G. Brett Robb, as Senior Scientific Director and Head of CRISPR Science to Drive Platform Expansion and Industrialization
    Full story
  • Sapio Sciences Advances The World's First AI-Powered Lab Assistant

    Sep 4, 2024, 08:05 AM by
    Sapio Sciences today announced significant enhancements to Sapio ELaiN, the pioneering AI-powered lab assistant that helps scientists streamline processes and work more efficiently. Sapio ELaiN is also now generally available after a successful beta launch in November 2023.
    Full story
  • Enzene appoints new site Lead for Flagship US continuous bioManufacturing facility

    Sep 4, 2024, 08:05 AM by
    Full story
  • Phreesia and American Academy of Pediatrics Join in Campaign to Increase Childhood MMR Vaccination

    Sep 3, 2024, 08:50 AM by
    Phreesia and the American Academy of Pediatrics (AAP) have joined forces to increase measles, mumps and rubella (MMR) immunization by reaching parents and caregivers of eligible or soon-to-be eligible children at the point of care. The collaboration comes as immunization rates have dipped in some communities, pointing to a need to improve access to the vaccines that can help keep children healthy.
    Full story
  • «
  • 21
  • 22 (current)
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy